Copyright © 2007, European Society of Cardiology
Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression
aDepartment of Medicine, University of Western Ontario, Canada
bDepartment of Physiology and Pharmacology, University of Western Ontario, Canada
cLawson Health Research Institute, London, Ontario, Canada
dDepartment of Pharmacology and Toxicology, University of Graz, Graz, Austria
* Corresponding author. Department of Physiology and Pharmacology, Medical Sciences Building, Rm. M254, University of Western Ontario, London, ON, Canada N6A 5C1. Tel.: +1 519 850 2989; fax: +1 519 661 3827. qfeng{at}uwo.ca
Objective We have recently demonstrated that endothelial nitric oxide synthase (eNOS) promotes cardiomyocyte proliferation. However, mechanisms by which eNOS regulates cardiomyocyte proliferation are not fully understood. The goal of the present study was to investigate the role of tissue inhibitor of metalloproteinase-3 (TIMP-3) in eNOS-mediated cardiomyocyte proliferation.
Methods and results Experiments were conducted in cultured neonatal mouse cardiomyocytes. TIMP-3 expression was significantly decreased in wild-type (WT) cardiomyocytes treated with an adenoviral eNOS (Ad-eNOS). Furthermore, TIMP-3 levels were significantly decreased in cardiomyocytes derived from eNOS transgenic mice. Conversely, TIMP-3 transcript levels were significantly elevated in eNOS–/– cardiomyocytes. The inhibitory effect of NO on TIMP-3 expression was dependent on S-nitrosylation of c-jun, a subunit of AP-1. Cell proliferation was increased in TIMP-3–/– cardiomyocytes while recombinant TIMP-3 decreased proliferation in both TIMP-3–/– and WT cardiomyocytes. Furthermore, the decline in proliferation observed in eNOS–/– cardiomyocytes was abrogated when TIMP-3 expression was blocked by an anti-TIMP-3 antibody. In vivo cardiomyocyte proliferation was assessed by Ki67 immunostaining on postnatal day 1 hearts. Ki67-positive cardiomyocytes were decreased in eNOS–/–, but increased in eNOS-Tg and TIMP-3–/– hearts compared to WT controls.
Conclusions Our study suggests that eNOS promotes neonatal cardiomyocyte proliferation by inhibiting TIMP-3 expression.
KEYWORDS Nitric oxide; Endothelial nitric oxide synthase; Cardiomyocyte; Tissue inhibitor of metalloproteinase-3; AP-1
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. E. Burger, F.-L. Xiang, L. Hammoud, D. L. Jones, and Q. Feng Erythropoietin Protects the Heart from Ventricular Arrhythmia during Ischemia and Reperfusion via Neuronal Nitric-Oxide Synthase J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 900 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hammoud, D. E. Burger, X. Lu, and Q. Feng Tissue inhibitor of metalloproteinase-3 inhibits neonatal mouse cardiomyocyte proliferation via EGFR/JNK/SP-1 signaling Am J Physiol Cell Physiol, April 1, 2009; 296(4): C735 - C745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Burger, F. Xiang, L. Hammoud, X. Lu, and Q. Feng Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H84 - H93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lamas, C. J. Lowenstein, and T. Michel Nitric oxide signaling comes of age: 20 years and thriving Cardiovasc Res, July 15, 2007; 75(2): 207 - 209. [Full Text] [PDF]
|
|